Literature DB >> 23756640

[Surgical aspects of malignant pleural mesothelioma: from the perspective of pathology].

A Fisseler-Eckhoff1.   

Abstract

The increased use of asbestos in Germany in the mid 1970s led occupational physicians, pulmonologists, thoracic surgeons and pathologists to the expectation of an increasing incidence and mortality in patients with pleural mesothelioma up to 2020. Prerequisite for curative surgery is a pathological anatomical tumor diagnosis on the basis of a biopsy and accurate tumor staging. In order to achieve reproducible results in the assessment of malignant pleural diseases, the pathological anatomical diagnosis of malignant pleural mesothelioma should be made according to the guidelines of the international mesothelioma interest group (IMIG). Currently used multimodal thoracic surgery therapeutic concepts present new challenges and problems to the pathological anatomical diagnosis and are discussed in this article.

Entities:  

Mesh:

Year:  2013        PMID: 23756640     DOI: 10.1007/s00104-012-2431-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  25 in total

Review 1.  The cytology of malignant mesothelioma.

Authors:  D Whitaker
Journal:  Cytopathology       Date:  2000-06       Impact factor: 2.073

2.  Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.

Authors:  Loïc Lang-Lazdunski; Andrea Bille; Rohit Lal; Paul Cane; Emma McLean; David Landau; Jeremy Steele; James Spicer
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

Review 3.  [Treatment strategy in pleural mesothelioma].

Authors:  J Schirren; T Muley; P Schneider; C Trainer; H Bülzebruck; H Dienemann; I Vogt-Moykopf
Journal:  Langenbecks Arch Chir Suppl Kongressbd       Date:  1998

4.  Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.

Authors:  Kyuichi Kadota; Kei Suzuki; Camelia S Sima; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2011-05       Impact factor: 15.609

Review 5.  An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.

Authors:  G Pasello; G L Ceresoli; A Favaretto
Journal:  Cancer Treat Rev       Date:  2012-03-27       Impact factor: 12.111

Review 6.  Pathological and molecular biological approaches to early mesothelioma.

Authors:  Tohru Tsujimura; Ikuko Torii; Ayuko Sato; Misa Song; Kazuya Fukuoka; Seiki Hasegawa; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2012-01-12       Impact factor: 3.402

7.  Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.

Authors:  Spasenija Savic; Noreli Franco; Bruno Grilli; Audrey de Vito Barascud; Michelle Herzog; Beata Bode; Heinz Loosli; Peter Spieler; René Schönegg; Inti Zlobec; Douglas P Clark; James G Herman; Lukas Bubendorf
Journal:  Chest       Date:  2010-02-05       Impact factor: 9.410

8.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Péchoux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

9.  Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Authors:  Aliya N Husain; Thomas Colby; Nelson Ordonez; Thomas Krausz; Richard Attanoos; Mary Beth Beasley; Alain C Borczuk; Kelly Butnor; Philip T Cagle; Lucian R Chirieac; Andrew Churg; Sanja Dacic; Armando Fraire; Francoise Galateau-Salle; Allen Gibbs; Allen Gown; Samuel Hammar; Leslie Litzky; Alberto M Marchevsky; Andrew G Nicholson; Victor Roggli; William D Travis; Mark Wick
Journal:  Arch Pathol Lab Med       Date:  2012-08-28       Impact factor: 5.534

10.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

View more
  1 in total

Review 1.  [Surgical therapy of malignant pleural mesothelioma].

Authors:  M Schirren; S Sponholz; S Oguzhan; A Fisseler-Eckhoff; A Fischer; J Schirren
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.